Heidelberg, September 5, 2025
150 Patients – 150 Times New Hope
We at PRECISIS are proud to announce a major milestone: 150 patients implanted with EASEE® across Europe.
Read moreNews
Good prospects for the future.
You can read about our progress and milestones, about our expansions and our experts, about our engagement and exchanges, in brief: about everything that motivates us.
Press Releases
![]()
![]()
Luxembourg/Heidelberg, July 24, 2025
European Investment Bank Backs Precisis with €20M Loan to Advance Breakthrough Neurostimulation Therapy in UK, Europe and US Markets
Precisis announced today the closing of a €20 million venture loan from the European Investment Bank (EIB)
Read more![]()
Heidelberg, July 1, 2025
Precisis focuses on international growth: Steven Griffiths appointed VP European Sales
Precisis, the Heidelberg-based MedTech company specializing in neuromodulation, has appointed Steven Griffiths as Vice President European Sales
Read more![]()
Heidelberg, May 22, 2025
Two Years, Real Results: EASEE® Therapy Brings Lasting Relief to People with Drug-Resistant Epilepsy
For people living with drug-resistant epilepsies, every day can feel uncertain. But a newly published long-term study offers a powerful message of hope: our EASEE® system has demon […]
Read more![]()
Newcastle, May 2, 2025
First UK Patient Received Revolutionary EASEE® Implant
Precisis is proud to announce a significant milestone in epilepsy treatment with the first UK patient undergoing surgery to fit the revolutionary EASEE® implant at the Royal Infirm […]
Read more![]()
Heidelberg, October 17, 2024
EASEE® System Successfully Implanted at Coimbra University Hospital
We are proud to announce a significant advancement in epilepsy treatment with the first successful implantation of our EASEE® epilepsy system at Coimbra University Hospital in Port […]
Read more![]()
Heidelberg, October 16, 2024
Precisis Celebrates Second Place at the HEALTH-i Award 2024
We are thrilled to announce that Precisis has achieved second place at the prestigious HEALTH-i Award 2024, a significant milestone in our journey towards revolutionizing epilepsy […]
Read more![]()
Berlin, September 13, 2024
PEARL Study Initiated to Assess the Long-Term Effects of the EASEE® Brain Stimulator – 135 People with Epilepsy* Can Participate
Technological devices that deliver electrical pulses to nerve tissue—known as neurostimulation therapies—have already helped many people alleviate chronic pain. Many Parkinson's pa […]
Read more![]()
Heidelberg/Berlin, September 3, 2024
MedTech Company Precisis Expands with Appointment of Top Executive as New CEO
Leading Neuromodulation Company, PRECISIS GmbH, Appoints Karl Stoklosa as New CEO Karl Stoklosa has been appointed as the new CEO of PRECISIS GmbH, a leading company in the field o […]
Read more![]()
Heidelberg, July 1, 2024
PRECISIS Unveils its Brain Pacemaker EASEE® III with Extended Three-Years Battery Life
From the heart of Heidelberg, PRECISIS, a leader in neuromodulation, proudly announces a significant leap in epilepsy treatment with the launch of EASEE® III.
Read more
